GH Research PLC (GHRS) shareholders
GHRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$18.25−0.02 (-0.11%)
Close on Nov 18, 2026Market cap $1.13BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
83.0%
51M of 62M shares
Institutional holders
63
18 new, 9 sold out
Net institutional buying
4M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Weston Nichols Joint filing with Lynx1 Capital Management LP (19.30%) | 13,263,288 | 19.30% | 13G (passive) amendment | Jun 30, 2026 |
| Lampert Mark N Joint filing with Bvf Partners L P/Il (14.20%), Bvf Inc/Il (14.20%) and 5 more | 8,827,712 | 14.20% | 13G (passive) amendment | Mar 31, 2025 |
| Lynx1 Capital Management LP Joint filing with Weston Nichols (13.90%) | 8,601,189 | 13.90% | 13G (passive) amendment | Sep 30, 2025 |
| Rajeev Shah Joint filing with RA Capital Management, L.P. (12.40%), Peter Kolchinsky (12.40%) and 1 more | 7,676,697 | 12.40% | 13G (passive) amendment | Jun 30, 2025 |
| FMR LLC Joint filing with Abigail P. Johnson (9.40%) | 6,482,945 | 9.40% | 13G (passive) amendment | Sep 30, 2026 |
| RTW Investments, LP Joint filing with Roderick Wong, M.D. (8.90%) | 5,499,769 | 8.90% | 13G (passive) amendment | Mar 31, 2025 |
| RA Capital Management, L.P. Joint filing with Peter Kolchinsky (7.10%), Rajeev Shah (7.10%) and 1 more | 4,897,182 | 7.10% | 13G (passive) amendment | Aug 12, 2026 |
| Abigail P. Johnson Joint filing with FMR LLC (6.90%) | 4,249,580 | 6.90% | 13G (passive) | Mar 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of GHRS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 13,263,288 | 21.38% | $356.52M | +2,500,000 | 41.19% |
| Bvf Inc/Il | 8,650,158 | 13.95% | $232.52M | – | 5.95% |
| Ra Capital Management, L.P. | 7,636,813 | 12.31% | $205.28M | −39,884 | 1.78% |
| FMR LLC | 5,977,045 | 9.64% | $160.66M | +841,000 | 0.01% |
| Rtw Investments, LP | 5,933,815 | 9.57% | $159.50M | – | 1.36% |
| Deep Track Capital, LP | 3,333,334 | 5.37% | $89.60M | New | 1.30% |
| Avoro Capital Advisors LLC | 1,800,000 | 2.90% | $48.38M | – | 0.43% |
| Foresite Capital Management VI LLC | 940,493 | 1.52% | $25.28M | +625,001 | 3.93% |
| Jefferies Financial Group Inc. | 712,300 | 1.15% | $19.15M | – | 0.13% |
| BlackRock, Inc. | 480,287 | 0.77% | $12.91M | +24,669 | 0.00% |
| UBS Group AG | 477,408 | 0.77% | $12.83M | +64,992 | 0.00% |
| Millennium Management LLC | 323,399 | 0.52% | $8.69M | −614,499 | 0.00% |
| Braidwell LP | 207,240 | 0.33% | $5.57M | New | 0.21% |
| Boothbay Fund Management, LLC | 202,103 | 0.33% | $5.43M | −80,788 | 0.07% |
| Jane Street Group, LLC | 169,951 | 0.27% | $4.57M | New | 0.00% |
| HighVista Strategies LLC | 158,770 | 0.26% | $4.27M | −54,442 | 0.97% |
| Trexquant Investment LP | 153,767 | 0.25% | $4.13M | +83,959 | 0.02% |
| Goldman Sachs Group Inc | 148,673 | 0.24% | $4.00M | +103,878 | 0.00% |
| XTX Topco Ltd | 86,986 | 0.14% | $2.34M | +34,896 | 0.03% |
| Citadel Advisors LLC | 85,952 | 0.14% | $2.31M | +20,488 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 63 | 51M | 83.0% | 18 / 18 | 16 / 9 | 8M | 4M |
| Q1 2026 | 54 | 48M | 76.7% | 12 / 19 | 13 / 10 | 4M | 3M |
| Q4 2025 | 53 | 47M | 75.1% | 15 / 17 | 15 / 8 | 6M | 4M |
| Q3 2025 | 47 | 45M | 71.8% | 14 / 18 | 10 / 5 | 4M | 3M |
| Q2 2025 | 38 | 44M | 70.3% | 7 / 14 | 10 / 5 | 2M | 1M |
| Q1 2025 | 36 | 43M | 68.7% | 14 / 10 | 8 / 8 | 14M | 2M |
| Q4 2024 | 31 | 31M | 49.5% | 6 / 7 | 6 / 2 | 1M | 1M |
| Q3 2024 | 28 | 31M | 49.2% | 4 / 6 | 8 / 3 | 1M | 0M |
| Q2 2024 | 28 | 30M | 49.1% | 2 / 7 | 8 / 6 | 1M | 1M |
| Q1 2024 | 32 | 30M | 48.6% | 6 / 7 | 9 / 9 | 3M | 2M |
| Q4 2023 | 35 | 30M | 48.2% | 6 / 8 | 7 / 0 | 3M | 2M |
| Q3 2023 | 29 | 29M | 46.8% | 1 / 14 | 3 / 6 | 2M | 3M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Aaron Luke Cameron | Chief Operating Officer | – | – | Apr 2, 2026 |
| Julie Ryan | VP, Finance | – | – | Apr 2, 2026 |
| Velichka Valcheva | Chief Executive Officer | – | – | Apr 2, 2026 |
| Magnus Clemensen Halle | Managing Director, Ireland | 118,354 | 0.19% | Apr 2, 2026 |
| Florian Schonharting | Director | 14,824,419 | 23.90% | Sep 9, 2026 |
| Dermot John Hanley | Director | 2,432 | 0.00% | Aug 13, 2026 |
| Michael Forer | Director | 45,509 | 0.07% | Aug 13, 2026 |
| Duncan Moore | Director | 14,600 | 0.02% | Aug 13, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
6.16%
2M shares short
Days to cover
6.5
At 0M shares a day
Change since last report
+3.4%
From 2M shares
Short volume, 20 days
61.0%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of GH Research's stock actually held short. Settlement fails (shares not delivered on time) peaked at 10,915 shares on Sep 21, 2026 over the last 90 days.
See a number that looks wrong?